Dear Editor, During a routine physical examination of a 55-year-old man, we found that he had a mass in the head of his left epididymis, which was harder than normal, with no obvious margin. He had no abnormality of other organs, including his skin, and imaging studies did not demonstrate masses or lymphadenopathy. The urologist decided to resect the left testicle along with the epididymis. Preoperative laboratory workups showed a white blood cell count of 3.8×10/L, a red blood cell count of 3.9×10/L, a leukocyte count of 0.9×10/L, serum calcium level of 2.18 mmol/L, and a serum phosphorus level of 0.78 mmol/L; all these values were lower than normal. His prostate-specific antigen level was 8.6 μg/L and his lactate dehydrogenase level had increased to 837 U/L. The patient underwent left orchectomy. Macroscopically, the left testicle appeared healthy and measured 5.5×4.5× 3.0 cm. The cut surface showed that the left epididymis was gray but the left testicle was healthy. Microscopically (Fig. 1), there were dilated capillaries and thin-walled small-vessel proliferation in the epididymis. The lumina of the vessels were filled with large, atypical lymphoid cells, but no tumor cells were apparent in the testicle. Immunohistochemical staining of the tumor cells produced positive findings for leukocyte common antigen, CD20 (Fig. 2), CD45RA, and CD79 and negative findings for CD3, CD43, and CD45RO. Test findings for CD5 and Epstein–Barr virus were negative. Test findings for prostatic acid phosphatase (PAP), a marker of prostatic cancer, were positive; findings for high-molecular-weight cytokeratin and low-molecular-weight cytokeratin were negative. The proliferation rate detected by monoclonal antibody Ki67 was nearly 85%. Therefore, the diagnosis was intravascular large B-cell lymphoma (IVLBL). We believe that the cancer occurred initially in the left epididymis. The patient’s marrow did not reveal large, atypical lymphoid cells. Seven days after surgery, the patient reported having a headache. Magnetic resonance imaging of his brain showed normal findings. However, 15 days later, a second round of imaging showed that the patient had several brain masses. The patient grew progressively weaker, so he was given intravenous nutrition in the hope that he would be able to withstand chemotherapy. Three days later, his condition had deteriorated markedly; 7 days after nutritional support began, he lapsed into a coma and died 3 days later. That is, the patient died without chemotherapy 1 month after surgery. According to the 2001 World Health Organization classification, IVLBL is a rare subtype of extranodal diffuse large B-cell lymphoma (DLBCL) characterized by the presence of lymphoma cells only in the lumina of small vessels, particularly capillaries. This uncommon lymphoma of B-cell lineage was originally described in 1959 by Pfleger and Tappeiner [5]. It occurs in adults, and the central nervous system and skin are the most common sites, although it can occur primarily in almost any organ. Imaging techniques have limited value because the tumor usually is not a visible mass, making the diagnosis of IVLBL difficult. The diagnosis is not even made in some patients until after their death. Clinical symptoms are variable; neurologic symptoms and skin lesions are perhaps the most common. Some patients have presented with a fever of unknown origin, with X. Ma :H. Liu (*) Department of Pathology, Changzheng Hospital, Second Military Medical University, No. 415, Fengyang Road, Shanghai 200003, China e-mail: liuhuimin2001@126.com